Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients-Reference-Cited by-同舟云学术

Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients

Published:2015-10 Issue:19 Volume:24 Page:2207-2218
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Taguchi Akihiko¹²,Sakai Chiaki³⁴,Soma Toshihiro⁵,Kasahara Yukiko¹,Stern David M.⁶,Kajimoto Katsufumi²,Ihara Masafumi¹²,Daimon Takashi⁷,Yamahara Kenichi⁸,Doi Kaori⁹,Kohara Nobuo¹⁰,Nishimura Hiroyuki¹¹,Matsuyama Tomohiro¹²,Naritomi Hiroaki²,Sakai Nobuyuki³⁴,Nagatsuka Kazuyuki²

Affiliation:

1. Department of Regenerative Medicine Research, Institute of Biomedical Research and Innovation, Kobe, Japan.

2. Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Japan.

3. Department of Endovascular Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan.

4. Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Japan.

5. Department of Hematology, Hyogo College of Medicine, Nishinomiya, Japan.

6. Executive Dean's Office, University of Tennessee, Memphis, Tennessee.

7. Department of Biostatistics, Hyogo College of Medicine, Nishinomiya, Japan.

8. Department of Regenerative Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

9. Department of Nursing, National Cerebral and Cardiovascular Center, Suita, Japan.

10. Department of Neurology, Kobe City Medical Center General Hospital, Kobe, Japan.

11. Department of Neurology, Nishinomiya Kyoritsu Neurosurgical Hospital, Nishinomiya, Japan.

12. Institute for Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2015.0160

Reference47 articles.

1. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke

2. Circulating CD34-Positive Cells Provide an Index of Cerebrovascular Function

3. Increase in Circulating CD34-Positive Cells in Patients with Angiographic Evidence of Moyamoya-like Vessels

4. Circulating CD34-Positive Cells Provide a Marker of Vascular Risk Associated with Cognitive Impairment

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Aging Immune System: A Critical Attack on Ischemic Stroke;Molecular Neurobiology;2024-09-14

2. Direct Water-Soluble Molecules Transfer from Transplanted Bone Marrow Mononuclear Cell to Hippocampal Neural Stem Cells;Stem Cells and Development;2024-09-01

3. Stem cell therapy: a new hope for stroke and traumatic brain injury recovery and the challenge for rural minorities in South Carolina;Frontiers in Neurology;2024-08-09

4. Current Stem Cell-Based Clinical Trials and Protective Phenotypic Conversion Cell Therapies Against Ischemic stroke;Comprehensive Hematology and Stem Cell Research;2024

5. A Randomized, Placebo-Controlled, Phase II Trial of Intravenous Allogeneic Non-HLA Matched, Unrelated Donor, Cord Blood Infusion for Ischemic Stroke;Stem Cells Translational Medicine;2023-12-10